Skip to main content
Premium Trial:

Request an Annual Quote

Liebman Leaves Wyeth to Head Roche's Global Computational Genetics

Premium

PALO ALTO, Calif.--Michael Liebman last week left his position as director of biomedical informatics and pharmaco-genomics at Wyeth-Ayerst Research in Radnor, Pa., to become director of computational biology and global head of computational genetics for Roche Bioscience here. Liebman spent two years at Wyeth, and previously directed bioinformatics and genomics for Vysis. Liebman continues to hold professorships at Northwestern University in chemical engineering and at the university's Center for Biotechnology, and is a professor of biochemistry at Loyola University in Chicago.

Liebman told BioInform he expects his new position at Roche to "provide unique opportunities to start looking at the relationship between diagnostics and therapeutics, which is going to be managed through the integration of genetics and genomics, and which will play a major role in the future of medicine."

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.